Rubi fructus (rubus coreanus) inhibits differentiation to adipocytes in 3T3-L1 cells

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Jeong, Mi Young ^a   Kim, Hye Lin ^b   Park, Jinbong ^b   An, Hyo Jin ^c   Kim, Sung Hoon ^b   Kim, Su Jin ^d   So, Hong Seob ^a   Park, Raekil ^a   Um, Jae Young ^b   Hong, Seung Heon ^a  

^a Wonkwang University   (South Korea)

^b Kyung Hee University   (South Korea)

^c Department of Computer and Electronic Physics   (South Korea)

^d Daegu Haany University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOCYTE FATTY ACID BINDING PROTEIN 2; ADIPONECTIN; ANTIOBESITY AGENT; CCAAT ENHANCER BINDING PROTEIN ALPHA; FATTY ACID BINDING PROTEIN 4; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; RESISTIN; RUBUS COREANUS EXTRACT; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; FIBROBLAST; LIPID STORAGE; MEDICINAL PLANT; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN EXPRESSION; RUBUS; RUBUS COREANUS;

EID: 84888620065     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/475386     Document Type: Article

References (38)

1. Abate N., Obesity and cardiovascular disease: pathogenetic role of the metabolic syndrome and therapeutic implications. Journal of Diabetes and its Complications 2000 14 3 154 174 2-s2.0-0033824123 10.1016/S1056-8727(00)00067-2
2. Farmer S. R., Auwerx J., Adipose tissue: new therapeutic targets from molecular and genetic studies-IASO stock conference 2003 report. Obesity Reviews 2004 5 4 189 196 2-s2.0-7044270592 10.1111/j.1467-789X.2004.00157.x (Pubitemid 39423000)
3. Fu J., Oveisi F., Gaetani S., Lin E., Piomelli D., Oleoylethanolamide, an endogenous PPAR-alpha agonist, lowers body weight and hyperlipidemia in obese rats. Neuropharmacology 2005 48 8 1147 1153 2-s2.0-19444372260 10.1016/j.neuropharm.2005.02.013 (Pubitemid 40725987)
4. Unger R. H., Zhou Y. T., Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes 2001 50 1 S118 S121 2-s2.0-0035125917 (Pubitemid 32148232)
5. Ntambi J. M., Young-Cheul K., Adipocyte differentiation and gene expression. Journal of Nutrition 2000 130 12 3122 3126
6. Zhou Y., Wang D., Zhu Q., Gao X., Yang S., Xu A., Wu D., Inhibitory effects of a-769662, a novel activator of AMP-activated protein kinase, on 3T3-L1 adipogenesis. Biological and Pharmaceutical Bulletin 2009 32 6 993 998 2-s2.0-66549123846 10.1248/bpb.32.993
7. Lowell B. B., PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function. Cell 1999 99 3 239 242 2-s2.0-0033615353 10.1016/S0092-8674(00)81654-2 (Pubitemid 29519902)
8. Tontonoz P., Hu E., Graves R. A., Budavari A. I., Spiegelman B. M., mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes and Development 1994 8 10 1224 1234 2-s2.0-0028180070
9. Brun R. P., Kim J. B., Hu E., Altiok S., Spiegelman B. M., Adipocyte differentiation: a transcriptional regulatory cascade. Current Opinion in Cell Biology 1996 8 6 826 832 2-s2.0-0030560633 10.1016/S0955-0674(96)80084-6 (Pubitemid 26399943)
10. Morrison R. F., Farmer S. R., Hormonal signaling and transcriptional control of adipocyte differentiation. Journal of Nutrition 2000 130 12 2-s2.0-0034528578
11. Rosen E. D., Walkey C. J., Puigserver P., Spiegelman B. M., Transcriptional regulation of adipogenesis. Genes and Development 2000 14 11 1293 1307 2-s2.0-0034214246 (Pubitemid 30397073)
12. Jeon T., Hwang S. G., Hirai S., Matsui T., Yano H., Kawada T., Lim B. O., Park D. K., Red yeast rice extracts suppress adipogenesis by down-regulating adipogenic transcription factors and gene expression in 3T3-L1 cells. Life Sciences 2004 75 26 3195 3203 2-s2.0-5444223557 10.1016/j.lfs.2004.06.012 (Pubitemid 39361176)
13. Hwang J. T., Kwon D. Y., Yoon S. H., AMP-activated protein kinase: a potential target for the diseases prevention by natural occurring polyphenols. New Biotechnology 2009 26 1-2 17 22 2-s2.0-71749100220 10.1016/j.nbt.2009.03.005
14. Kim S. K., Kong C. S., Anti-adipogenic effect of dioxinodehydroeckol via AMPK activation in 3T3-L1 adipocytes. Chemico-Biological Interactions 2010 186 1 24 29 2-s2.0-77953020130 10.1016/j.cbi.2010.04.003
15. Huang B., Yuan H. D., Kim D. Y., Quan H. Y., Chung S. H., Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptor-gamma (PPARgamma) and AMP-activated protein kinase (AMPK) pathways. Journal of Agricultural and Food Chemistry 2011 59 8 3666 3673 2-s2.0-79955025463 10.1021/jf104814t
16. Qian Q., Liu X., He W., An Y., Chen Q., Wu J., Deng Y., Guo L., Zhang Y., Wang T., TG accumulation inhibitory effects of Jinqi formula by AMPK signaling pathway. Journal of Ethnopharmacology 2012 143 1 41 48 10.1016/j.jep.2012.05.052
17. Moon G. S., Constituents and Uses of Medicinal Herbs. 1991
18. Lim J. W., Jeong J. T., Shin C. S., Component analysis and sensory evaluation of Korean black raspberry (Rubus coreanus Mique) wines. International Journal of Food Science and Technology 2012 47 5 918 926 2-s2.0-84859706336 10.1111/j.1365-2621.2011.02922.x
19. Lim J. W., Hwang H. J., Shin C. S., Polyphenol compounds and anti-inflammatory activities of Korean black raspberry (Rubus coreanus Miquel) wines produced from juice supplemented with pulp and seed. Journal of Agricultural and Food Chemistry 2012 60 20 5121 5127 10.1021/jf205350k
20. Choi J., Lee K. T., Ha J., Yun S. Y., Ko C. D., Jung H. J., Park H. J., Antinociceptive and antiinflammatory effects of niga-ichigoside F1 and 23-hydroxytormentic acid obtained from Rubus coreanus. Biological and Pharmaceutical Bulletin 2003 26 10 1436 1441 2-s2.0-1542541354 10.1248/bpb.26.1436 (Pubitemid 41685396)
21. Lee J. E., Park E., Lee J. E., Auh J. H., Choi H. K., Lee J., Cho S., Kim J. H., Effects of a Rubus coreanus Miquel supplement on plasma antioxidant capacity in healthy Korean men. Nutrition Research and Practice 2011 5 5 429 434 2-s2.0-82755179441 10.4162/nrp.2011.5.5.429
22. Ramirez-Zacarias J. L., Castro-Munozledo F., Kuri-Harcuch W., Quantitation of adipose conversion and triglycerides by staining intracytoplasmic lipids with oil red O. Histochemistry 1992 97 6 493 497 2-s2.0-0026793195
23. Daval M., Foufelle F., Ferré P., Functions of AMP-activated protein kinase in adipose tissue. Journal of Physiology 2006 574 part 1 55 62 2-s2.0-33745183847 10.1113/jphysiol.2006.111484 (Pubitemid 43905796)
24. Tontonoz P., Hu E., Devine J., Beale E. G., Spiegelman B. M., PPAR gamma 2 regulates adipose expression of the phosphoenolpyruvate carboxykinase gene. Molecular and Cellular Biology 1995 15 1 351 357 2-s2.0-0028988487 (Pubitemid 24379933)
25. Rosen E. D., Hsu C. H., Wang X., Sakai S., Freeman M. W., Gonzalez F. J., Spiegelman B. M., C/EBPalpha induces adipogenesis through PPARgamma: a unified pathway. Genes & Development 2002 16 1 22 26 10.1101/gad.948702 (Pubitemid 34049634)
26. Glatz J. F. C., Börchers T., Spener F., Van Der Vusse G. J., Fatty acids in cell signalling: Modulation by lipid binding proteins. Prostaglandins Leukotrienes and Essential Fatty Acids 1995 52 2-3 121 127 2-s2.0-0028819571 10.1016/0952-3278(95)90010-1
27. Steppan C. M., Bailey S. T., Bhat S., Brown E. J., Banerjee R. R., Wright C. M., Patel H. R., Ahima R. S., Lazar M. A., The hormone resistin links obesity to diabetes. Nature 2001 409 6818 307 312 2-s2.0-0035905758 10.1038/35053000 (Pubitemid 32151228)
28. Rajala M. W., Obici S., Scherer P. E., Rossetti L., Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. Journal of Clinical Investigation 2003 111 2 225 230 2-s2.0-0037241112 10.1172/JCI200316521 (Pubitemid 36105921)
29. Yim M.J., Hosokawa M., Mizushina Y., Yoshida H., Saito Y., Miyashita K., Suppressive effects of amarouciaxanthin A on 3T3-L1 adipocyte differentiation through down-regulation of PPARgamma and C/EBPalpha mRNA expression. Journal of Agricultural and Food Chemistry 2011 59 5 1646 1652 2-s2.0-79952153349 10.1021/jf103290f
30. Cho E. J., Rahman A., Kim S. W., Baek Y. M., Hwang H. J., Oh J. Y., Hwang H. S., Lee S. H., Yun J. W., Chitosan oligosaccharides inhibit adipogenesis in 3T3-L1 adipocytes. Journal of Microbiology and Biotechnology 2008 18 1 80 87 2-s2.0-43749105179
31. Kadowaki T., Yamauchi T., Adiponectin and adiponectin receptors. Endocrine Reviews 2005 26 3 439 451 2-s2.0-18844432308 10.1210/er.2005-0005 (Pubitemid 40686653)
32. Yamauchi T., Kamon J., Waki H., Terauchi Y., Kubota N., Hara K., Mori Y., Ide T., Murakami K., Tsuboyama-Kasaoka N., Ezaki O., Akanuma Y., Gavrilova O., Vinson C., Reitman M. L., Kagechika H., Shudo K., Yoda M., Nakano Y., Tobe K., Nagai R., Kimura S., Tomita M., Froguel P., Kadowaki T., The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Medicine 2001 7 8 941 946 2-s2.0-17944365228 10.1038/90984 (Pubitemid 32756432)
33. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., Matsuzawa Y., PPARgamma ligands Increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001 50 9 2094 2099 2-s2.0-0035462629 (Pubitemid 33643677)
34. Moon H. S., Chung C. S., Lee H. G., Kim T. G., Choi Y. J., Cho C. S., Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells. Obesity 2007 15 11 2571 2582 2-s2.0-38049030825 10.1038/oby.2007.309
35. Daval M., Foufelle F., Ferré P., Functions of AMP-activated protein kinase in adipose tissue. Journal of Physiology 2006 574 part 1 55 62 2-s2.0-33745183847 10.1113/jphysiol.2006.111484 (Pubitemid 43905796)
36. Giri S., Rattan R., Haq E., Khan M., Yasmin R., Won J. S., Key L., Singh A. K., Singh I., AICAR inhibits adipocyte differentiation in 3T3L1 and restores metabolic alterations in diet-induced obesity mice model. Nutrition & Metabolism 2006 3 article 31 2-s2.0-33748612432 10.1186/1743-7075-3-31 (Pubitemid 44378734)
37. Gao Y., Zhou Y., Xu A., Wu D., Effects of an AMP-activated protein kinase inhibitor, compound C, on adipogenic differentiation of 3T3-L1 cells. Biological and Pharmaceutical Bulletin 2008 31 9 1716 1722 2-s2.0-51449094922 10.1248/bpb.31.1716
38. Nam M., Lee W. H., Bae E. J., Kim S. G., Compound C inhibits clonal expansion of preadipocytes by increasing p21 level irrespectively of AMPK inhibition. Archives of Biochemistry and Biophysics 2008 479 1 74 81 2-s2.0-53649106018 10.1016/j.abb.2008.07.029